The management of multiple sclerosis. 3. Apparent suppression of symptoms by an estrogen-progestin compound.
D000328:Adult; D005260:Female; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009641:Norethynodrel / Q000627:therapeutic use*
D009641:Norethynodrel